Outcomes of Hematopoietic Stem Cell Transplantation by Donor Types in Children with Acute Myeloid Leukemia

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  2016-10-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.15264/CPHO.2016.23.2.145
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Pediatric AML: From Biology to Clinical Management

  2015cited by this paper
• Similar outcomes of allogeneic hematopoietic cell transplantation from unrelated donor and umbilical cord blood vs. sibling donor for pediatric acute myeloid leukemia: Multicenter experience in China

  2015cited by this paper
• Similar outcomes between adolescent/young adults and children with AML following allogeneic hematopoietic cell transplantation

  2014cited by this paper
• Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens.

  2014cited by this paper
• Factors predictive of relapse of acute leukemia in children after allogeneic hematopoietic cell transplantation.

  2014cited by this paper
• Comparable survival for pediatric acute myeloid leukemia with poor‐risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation

  2014cited by this paper
• Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysis

  2014cited by this paper
• Epidemiology of childhood acute myeloid leukemia

  2013cited by this paper
• Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia.

  2013cited by this paper
• Allogeneic hematopoietic cell transplantation in first remission abrogates poor outcomes associated with high-risk pediatric acute myeloid leukemia.

  2013cited by this paper
• Does matched unrelated donor transplantation have the same outcome as matched sibling transplantation in unselected patients?

  2012cited by this paper
• Investigation of the freely available easy-to-use software ‘EZR' for medical statistics

  2012cited by this paper
• The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study

  2012cited by this paper
• Transplantation for AML in children.

  2012cited by this paper
• Favorable Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Children With High-risk or Advanced Acute Myeloid Leukemia

  2011cited by this paper
• A review on allogeneic stem cell transplantation for newly diagnosed pediatric acute myeloid leukemia.

  2010cited by this paper
• Impact of disease risk on efficacy of matched related bone marrow transplantation for pediatric acute myeloid leukemia: the Children's Oncology Group.

  2008cited by this paper
• A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients.

  2007cited by this paper
• Umbilical cord blood transplantation: a new alternative option.

  2005cited by this paper
• Pediatric acute myeloid leukemia: international progress and future directions

  2005cited by this paper
• A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission.

  2001cited by this paper
• Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.

  2001cited by this paper
• The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

  1998cited by this paper
• On call in... bone marrow transplantation

  1996cited by this paper
• Induction chemotherapy with idarubicin plus N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute myelogenous leukemia: a newly designed induction regimen--a prospective, cooperative multicenter study.

  1996cited by this paper
• Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

  1980cited by this paper
• CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S

  1974cited by this paper

• No citing papers are available for this paper.